Systematic ReviewResearchPatient Education

Nurse-led self-care programs improved quality of life and anxiety in heart failure patients

Journal of Clinical Nursing (PubMed)Apr 1, 2024

AI-summarized from the linked source. Educational brief, not medical advice.

Brief summary

A systematic review and meta-analysis found that nurse-led self-care interventions improved quality of life, anxiety, and symptom burden in people with heart failure.

What NurseJet pulled from the source

Across 25 randomized controlled trials and 2,746 participants, nurse-led self-care interventions improved quality of life (SMD 0.83), anxiety (MD 1.39, high-certainty evidence), and symptom burden (SMD 0.81) versus usual care. No significant effect was seen on all-cause readmission or emergency department visits, and effects on mortality and sleep quality were unclear.

Why this matters for nurses

Heart failure self-care, including daily weights, sodium and fluid awareness, symptom recognition, and medication adherence, is taught and reinforced largely by nurses. This may matter for nurses because it gives meta-analytic support that structured nurse-led teaching improves how patients feel and cope, even where it did not change readmissions.

Bedside takeaway

Be aware that nurse-led heart failure self-care teaching improved quality of life, anxiety, and symptom burden, but did not significantly change readmissions or emergency department visits.

Key takeaways

Across 25 RCTs and 2,746 patients, nurse-led self-care improved quality of life, anxiety, and symptom burden.
The anxiety benefit was supported by high-certainty evidence.
No significant effect was seen on all-cause readmission or ED visits.
Effects on mortality and sleep quality were unclear.

Practice implications

Prioritize structured heart failure self-care teaching such as daily weights, symptom tracking, sodium and fluid guidance, and medication adherence, use teach-back to confirm understanding, and set realistic expectations that the strongest gains were in quality of life and symptoms rather than readmissions.

Limitations & cautions

Certainty varied by outcome, and effects on readmission and mortality were not demonstrated. Interventions differed across trials, so the exact dose of teaching that helps is unclear.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations

Exact source links

Open source

Public citations are filtered to exact credible source pages. Homepage-only or invalid links stay in admin review and are not shown here.

Journal of Clinical Nursing (PubMed)

Journal of Clinical Nursing (PubMed). Effects of nurse-led self-care interventions on health outcomes among people with heart failure: A systematic review and meta-analysis.

Open original source

https://pubmed.ncbi.nlm.nih.gov/38041606/

Professional education only

This summary does not replace clinical judgment, facility policy, provider orders, or official guidelines. Verify practice changes against the original source and local protocol.

Related briefs

More updates for this clinical area

Back to Discover

European heart journal (PubMed)Sep 6, 2026Research Article

In the pragmatic TARGET-D randomized trial, vitamin D dosing titrated to a serum target did not significantly reduce the composite of death, recurrent myocardial infarction, heart-failure hospitalization, or stroke after myocardial infarction.

Telemetry Med-SurgAI summaryReview source

Research ArticleResearchMedication SafetyPatient EducationAI summary · original source linked below

Among 630 participants followed for an average of 4.2 years, major cardiovascular events occurred in 15.7% with targeted vitamin D management and 18.4% with usual care (hazard ratio 0.85, 95% CI 0.58 to 1.24; P=0.40).

Key takeaways

At baseline, 87% of participants had a 25-hydroxyvitamin D level of 40 ng/mL or lower.
The primary composite outcome and the individual outcomes of death, heart-failure hospitalization, and stroke were not significantly different.
A lower recurrent-MI rate was a secondary finding and should not override the nonsignificant primary result.

Why this matters on shift

The trial cautions against presenting targeted vitamin D supplementation as a proven strategy for reducing major cardiovascular events after myocardial infarction.

Bedside takeaway

Present vitamin D as prescribed supplementation, not as a replacement for established post-MI secondary prevention.

Nursing implications

Reinforce the prescribed secondary-prevention plan and avoid implying that vitamin D replaces therapies with established post-MI benefit.

Limitations & cautions

Abstract-only summary. The trial included 630 participants, 78.1% were men, the primary confidence interval included benefit and no benefit, and individual secondary outcomes were not the primary endpoint.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

European heart journal (PubMed). Targeted vitamin D supplementation and major adverse cardiovascular events after myocardial infarction: the TARGET-D trial.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

Journal of neurology (PubMed)Sep 6, 2026Systematic Review

A cumulative meta-analysis found longer survival over time in Duchenne muscular dystrophy, alongside a shift from predominantly respiratory toward cardiac causes of death.

Peds ICUAI summaryReview source

Systematic ReviewResearchPatient EducationAI summary · original source linked below

The review included 53 studies and more than 13,000 patients. Pooled median survival was 29 years among ventilated patients and 19 years among non-ventilated patients, but these study-level observational comparisons do not establish that ventilation alone caused the difference.

Key takeaways

Sixty percent of patients in the included studies received home mechanical ventilation.
Survival improved progressively over time in both ventilated and non-ventilated groups.
As respiratory survival improved, cardiac and other causes accounted for a larger share of deaths.

Why this matters on shift

Patients living longer with Duchenne muscular dystrophy may need sustained respiratory support plus ongoing cardiac and multisystem surveillance across care transitions.

Bedside takeaway

Verify each patient's established respiratory and cardiac plan during admissions and care transitions.

Nursing implications

During admissions and handoffs, verify the established ventilation, airway-clearance, and cardiac-monitoring plan and coordinate concerns with the multidisciplinary team.

Limitations & cautions

Abstract-only summary. This was a study-level meta-analysis of heterogeneous observational survival reports; the ventilated and non-ventilated groups were not randomized, so associations should not be interpreted as treatment effects.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

Journal of neurology (PubMed). Improving survival in Duchenne muscular dystrophy across eras: a systematic review and cumulative meta-analysis.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

Heart rhythm (PubMed)Sep 4, 2026Clinical Guideline

A 2026 HRS/PACES scientific statement offers evidence-informed practical advice for antiarrhythmic use in clinical scenarios underrepresented in trials.

Telemetry Med-SurgAI summaryReview source

Clinical GuidelineGuidelineMedication SafetyAI summary · original source linked below

The statement identifies common scenarios in which antiarrhythmic-drug evidence and guidance are limited, then explains the rationale for recommendations using available evidence and expert clinical proficiency.

Key takeaways

The document focuses on scenarios that are not well represented in antiarrhythmic-drug trials.
Its practical advice combines the available evidence with multidisciplinary expert experience.
The abstract does not support applying one antiarrhythmic approach across all understudied situations.

Why this matters on shift

Antiarrhythmics can require close rhythm, hemodynamic, and adverse-effect surveillance in patients whose circumstances fall outside typical trial populations.

Bedside takeaway

Verify the scenario-specific treatment and monitoring plan, then follow provider orders and local medication-safety protocols.

Nursing implications

Verify the scenario-specific treatment and monitoring plan, then follow provider orders and local medication-safety protocols.

Limitations & cautions

Abstract-only summary. The abstract does not enumerate individual recommendations, patient groups, drug choices, doses, or monitoring thresholds.
AI-summarized from the linked source. Review the original statement before applying to practice.

Citations · exact source links

Heart rhythm (PubMed). 2026 HRS/PACES scientific statement on the use of antiarrhythmic drugs in understudied clinical scenarios.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

Practice implications

Limitations & cautions

Exact source links

More updates for this clinical area

Targeted vitamin D did not significantly reduce major cardiovascular events after MI

Duchenne survival has improved as respiratory and cardiac care evolved

HRS and PACES address antiarrhythmic use in understudied clinical scenarios